Charles Schwab Investment Management Inc. Acquires 3,048 Shares of ICU Medical, Inc. (NASDAQ:ICUI)

Charles Schwab Investment Management Inc. grew its stake in shares of ICU Medical, Inc. (NASDAQ:ICUI - Free Report) by 1.0% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 304,155 shares of the medical instruments supplier's stock after acquiring an additional 3,048 shares during the period. Charles Schwab Investment Management Inc. owned 1.24% of ICU Medical worth $47,196,000 at the end of the most recent quarter.

Several other hedge funds have also recently bought and sold shares of the stock. Venturi Wealth Management LLC raised its position in shares of ICU Medical by 1,510.0% in the third quarter. Venturi Wealth Management LLC now owns 322 shares of the medical instruments supplier's stock valued at $59,000 after buying an additional 302 shares in the last quarter. Point72 Hong Kong Ltd acquired a new stake in shares of ICU Medical in the third quarter valued at approximately $72,000. Smartleaf Asset Management LLC raised its position in shares of ICU Medical by 166.8% in the fourth quarter. Smartleaf Asset Management LLC now owns 907 shares of the medical instruments supplier's stock valued at $140,000 after buying an additional 567 shares in the last quarter. Coldstream Capital Management Inc. acquired a new stake in shares of ICU Medical in the third quarter valued at approximately $227,000. Finally, OLD National Bancorp IN raised its position in shares of ICU Medical by 22.0% in the fourth quarter. OLD National Bancorp IN now owns 1,462 shares of the medical instruments supplier's stock valued at $227,000 after buying an additional 264 shares in the last quarter. 96.10% of the stock is currently owned by institutional investors and hedge funds.

Remove Ads

Wall Street Analysts Forecast Growth

A number of research firms have recently weighed in on ICUI. Raymond James set a $97.00 price target on shares of ICU Medical in a research report on Wednesday, March 12th. StockNews.com upgraded shares of ICU Medical from a "hold" rating to a "buy" rating in a research report on Tuesday. Finally, Jefferies Financial Group upgraded shares of ICU Medical from a "hold" rating to a "buy" rating and set a $200.00 price objective for the company in a research report on Wednesday, December 11th. One analyst has rated the stock with a hold rating, three have issued a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of "Buy" and a consensus target price of $168.67.

Insiders Place Their Bets

In other ICU Medical news, CEO Vivek Jain sold 1,373 shares of the business's stock in a transaction on Thursday, January 2nd. The shares were sold at an average price of $155.48, for a total transaction of $213,474.04. Following the sale, the chief executive officer now owns 104,593 shares of the company's stock, valued at approximately $16,262,119.64. The trade was a 1.30 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Insiders own 6.70% of the company's stock.

ICU Medical Price Performance

Shares of NASDAQ ICUI traded down $1.08 during midday trading on Tuesday, reaching $148.13. 180,347 shares of the company were exchanged, compared to its average volume of 255,637. The stock's 50-day moving average price is $156.96 and its 200-day moving average price is $164.86. The stock has a market cap of $3.63 billion, a P/E ratio of -32.41 and a beta of 0.73. ICU Medical, Inc. has a one year low of $93.36 and a one year high of $196.26. The company has a quick ratio of 1.03, a current ratio of 2.29 and a debt-to-equity ratio of 0.75.

ICU Medical Company Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.